{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T12:22:40Z","timestamp":1790252560773,"version":"4.1.0"},"reference-count":63,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,3,7]],"date-time":"2023-03-07T00:00:00Z","timestamp":1678147200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> Patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI) therapy may experience further damage to the vascular endothelium, leading to increased inflammatory response and in-stent thrombosis. In many clinical studies, sodium tanshinone IIA sulfonate injection (STS) has been found to reduce inflammatory factors and enhance vascular endothelial function in patients with ACS while improving the prognosis of PCI. However, to date, there has been no systematic review assessing the effectiveness and safety of STS on inflammatory factors and vascular endothelial function.<\/jats:p><jats:p><jats:bold>Purpose:<\/jats:bold> The aim of this study is to systematically review the effects of STS on inflammatory factors and endothelial function in patients with ACS treated with PCI.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> Until October 2022, eight literature databases and two clinical trial registries were searched for randomized controlled trials (RCTs) investigating STS treatment for ACS patients undergoing PCI. The quality of the included studies was assessed using the Cochrane Risk Assessment Tool 2.0. Meta-analysis was performed using RevMan 5.4 software.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> Seventeen trials met the eligibility criteria, including 1,802 ACS patients undergoing PCI. The meta-analysis showed that STS significantly reduced high-sensitivity C-reactive protein (hs-CRP) levels (mean difference [MD = \u22122.35, 95% CI (\u22123.84, \u22120.86), <jats:italic>p<\/jats:italic> = 0.002], tumor necrosis factor-alpha (TNF-\u03b1) levels (standard mean difference [SMD = \u22123.29, 95%CI (\u22125.15, \u22121.42), <jats:italic>p<\/jats:italic> = 0,006], matrix metalloproteinase-9 (MMP-9) levels [MD = \u221216.24, 95%CI (\u221217.24, \u221215.24), <jats:italic>p<\/jats:italic> &amp;lt; 0.00001], and lipid peroxidation (LPO) levels [MD = \u22122.32, 95%CI (\u22122.70, \u22121.93), <jats:italic>p<\/jats:italic> &amp;lt; 0.00001], and increased superoxide dismutase (SOD) levels [SMD = 1.46, 95%CI (0.43, 2.49), <jats:italic>p<\/jats:italic> = 0,006] in patients with ACS. In addition, STS significantly decreased the incidence of major adverse cardiovascular events (relative risk = 0.54, 95%CI [0.44, 0.66], <jats:italic>p<\/jats:italic> &amp;lt; 0.00001). The quality of evidence for the outcomes was assessed to be very low to medium.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> STS can safely and effectively reduce the levels of hs-CRP, TNF-\u03b1, MMP-9, and LPO and increase the level of SOD in patients with ACS treated with PCI. It can also reduce the incidence of adverse cardiovascular events. However, these findings require careful consideration due to the small number of included studies, high risk of bias, and low to moderate evidence. In the future, more large-scale and high-quality RCTs will be needed as evidence in clinical practice.<\/jats:p>","DOI":"10.3389\/fphar.2023.1144419","type":"journal-article","created":{"date-parts":[[2023,3,7]],"date-time":"2023-03-07T04:29:54Z","timestamp":1678163394000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["Effects of sodium tanshinone IIA sulfonate injection on inflammatory factors and vascular endothelial function in patients with acute coronary syndrome undergoing percutaneous coronary intervention: A systematic review and meta-analysis of randomized clinical trials"],"prefix":"10.3389","volume":"14","author":[{"given":"Zunqi","family":"Kan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenli","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengqi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanyu","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqing","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongmei","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,3,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.jclinepi.2010.07.015","article-title":"GRADE guidelines: 3. Rating the quality of evidence","volume":"64","author":"Balshem","year":"2011","journal-title":"J. Clin. Epidemiol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"e56","DOI":"10.1161\/cir.0000000000000659","article-title":"Heart disease and stroke statistics-2019 update: A report from the American heart association","volume":"139","author":"Benjamin","year":"2019","journal-title":"Circulation"},{"key":"B3","doi-asserted-by":"publisher","first-page":"e012874","DOI":"10.1161\/jaha.119.012874","article-title":"Risk of major adverse cardiovascular events and major hemorrhage among white and black patients undergoing percutaneous coronary intervention","volume":"8","author":"Cai","year":"2019","journal-title":"J. Am. Heart Assoc."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1016\/j.hlc.2016.02.023","article-title":"Monocyte to HDL cholesterol ratio predicts coronary artery disease severity and future major cardiovascular adverse events in acute coronary syndrome","volume":"25","author":"Cetin","year":"2016","journal-title":"Heart Lung Circ."},{"key":"B5","doi-asserted-by":"publisher","first-page":"e006363","DOI":"10.1161\/circoutcomes.119.006363","article-title":"Effects of percutaneous coronary intervention on death and myocardial infarction stratified by stable and unstable coronary artery disease: A meta-analysis of randomized controlled trials","volume":"13","author":"Chacko","year":"2020","journal-title":"Circ. Cardiovasc Qual. Outcomes"},{"key":"B6","first-page":"1886","article-title":"Influence of Tanshinone IIa Injection combined with Yiqi Fumai Injection on cardiac function in patients with acute myocardial infarction after PCI","volume":"32","author":"Chen","year":"2017","journal-title":"China J. Traditional Chin. Med. Pharm."},{"key":"B7","doi-asserted-by":"publisher","first-page":"5763","DOI":"10.21037\/apm-21-681","article-title":"Efficacy and safety of integrated traditional Chinese medicine and standard western medicine for patients with acute coronary syndrome: Protocol for a systematic review and meta-analysis","volume":"10","author":"Cheng","year":"2021","journal-title":"Ann. Palliat. Med."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.3892\/mmr.2017.6760","article-title":"Sodium tanshinone IIA sulfonate suppresses heat stress-induced endothelial cell apoptosis by promoting NO production through upregulating the PI3K\/AKT\/eNOS pathway","volume":"16","author":"Cheng","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"B9","doi-asserted-by":"publisher","first-page":"329","DOI":"10.6515\/acs20161205a","article-title":"The management and prognostic factors of acute coronary syndrome: Evidence from the taiwan acute coronary syndrome full spectrum Registry","volume":"33","author":"Chu","year":"2017","journal-title":"Acta Cardiol. Sin."},{"key":"B10","doi-asserted-by":"publisher","first-page":"e588","DOI":"10.1093\/pubmed\/fdac036","article-title":"Strengthening systematic reviews in public health: Guidance in the Cochrane Handbook for systematic reviews of interventions, 2nd edition","volume":"44","author":"Cumpston","year":"2022","journal-title":"J. Public Health (Oxf)"},{"key":"B11","doi-asserted-by":"publisher","first-page":"554","DOI":"10.3969\/j.issn.1672-5301.2018.06.020","article-title":"Study on the observation and treatment of ventricular premature beats after PCI","volume":"16","author":"Du","year":"2018","journal-title":"Chin. J. Cardiovasc. Res."},{"key":"B12","doi-asserted-by":"publisher","first-page":"349","DOI":"10.3969\/j.issn.1009-0126.2011.04.019","article-title":"Effects of sodium tanshinone II A sulfonate on arrhythmia induced by myocardial ischemia-reperfusion","volume":"13","author":"Du","year":"2011","journal-title":"Chin. J. Geriatric Heart Brain Vessel Dis."},{"key":"B13","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1001\/jamacardio.2016.2049","article-title":"Updates on acute coronary syndrome: A review","volume":"1","author":"Eisen","year":"2016","journal-title":"JAMA Cardiol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1159\/000491768","article-title":"Comparison of the effects of ticagrelor and clopidogrel on inflammatory factors, vascular endothelium functions and short-term prognosis in patients with acute ST-segment elevation myocardial infarction undergoing emergency percutaneous coronary intervention: A pilot study","volume":"48","author":"Gao","year":"2018","journal-title":"Cell Physiol. Biochem."},{"key":"B15","doi-asserted-by":"publisher","first-page":"263","DOI":"10.3389\/fphar.2018.00263","article-title":"Sodium tanshinone IIA sulfonate decreases cigarette smoke-induced inflammation and oxidative stress via blocking the activation of MAPK\/HIF-1\u03b1 signaling pathway","volume":"9","author":"Guan","year":"2018","journal-title":"Front. Pharmacol."},{"key":"B16","volume-title":"Efficacy and safety of danshen injection in treating patients with unstable angina pectoris of qi deficiency and blood stasis type in perioperative period of interventional therapy: A clinical study of the efficacy and safety of IIA","author":"He","year":"2016"},{"key":"B17","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3969\/j.issn.2095-8439.2019.05.122","article-title":"Study on Chinese medicine intervention in perioperative period of acute coronary syndrome","volume":"6","author":"He","year":"2019","journal-title":"Diet. health care"},{"key":"B18","doi-asserted-by":"publisher","first-page":"8172714","DOI":"10.1155\/2020\/8172714","article-title":"High-fat diet aggravates acute pancreatitis via TLR4-mediated necroptosis and inflammation in rats","volume":"2020","author":"Hong","year":"2020","journal-title":"Oxid. Med. Cell Longev."},{"key":"B19","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1007\/s12975-017-0526-6","article-title":"Sodium tanshinone IIA sulfonate enhances effectiveness rt-PA treatment in acute ischemic stroke patients associated with ameliorating blood-brain barrier damage","volume":"8","author":"Ji","year":"2017","journal-title":"Transl. Stroke Res."},{"key":"B20","doi-asserted-by":"publisher","first-page":"9","DOI":"10.12669\/pjms.38.1.4413","article-title":"Effect of Tirofiban Injection on vascular endothelial function, cardiac function and inflammatory cytokines in patients with acute myocardial infarction after emergency Percutaneous Coronary Intervention","volume":"38","author":"Kang","year":"2022","journal-title":"Pak J. Med. Sci."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1253\/circj.CJ-19-0133","article-title":"JCS 2018 guideline on diagnosis and treatment of acute coronary syndrome","volume":"83","author":"Kimura","year":"2019","journal-title":"Circ. J."},{"key":"B22","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/s41598-017-18745-5","article-title":"Tanshinone IIA sulfonate protects against cigarette smoke-induced COPD and down-regulation of CFTR in mice","volume":"8","author":"Li","year":"2018","journal-title":"Sci. Rep."},{"key":"B23","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.jiph.2019.06.019","article-title":"Epidemiological analysis of norovirus infectious diarrhea outbreaks in Chongqing, China, from 2011 to 2016","volume":"13","author":"Li","year":"2020","journal-title":"Health horiz."},{"key":"B24","doi-asserted-by":"publisher","first-page":"17451","DOI":"10.1038\/s41598-017-16980-4","article-title":"Sodium tanshinone IIA sulfate adjunct therapy reduces high-sensitivity C-reactive protein level in coronary artery disease patients: A randomized controlled trial","volume":"7","author":"Li","year":"2017","journal-title":"Sci. Rep."},{"key":"B25","volume-title":"The influence of percutaneous coronary intervention (PCI) myocardial injury of sodium tanshinone \u2161A sulfonate in patients with acute coronary syndrome","author":"Li","year":"2016"},{"key":"B26","volume-title":"Clinical study of the effect of tanshinone \u2161A sodium sulfonate on coronary microcirculation in patients with acute coronary syndrome","author":"Lian","year":"2020"},{"key":"B27","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3969\/j.issn.1674-4055.2017.01.17","article-title":"Influence of sodium tanshinone \u2161A sulfonate on oxidative stress level in patients with acute coronary syndrome","volume":"9","author":"Lin","year":"2017","journal-title":"Chin. J. Evidence-Based Cardiovasc. Med."},{"key":"B28","volume-title":"Effect of tanshinone \u2161A and Salvia miltiorrhiza injection on myocardial injury during perioperative PCI","author":"Lin","year":"2012"},{"key":"B29","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.ijbiomac.2020.02.040","article-title":"Sodium tanshinone IIA sulfonate protects against A\u03b2(1-42)-induced cellular toxicity by modulating A\u03b2-degrading enzymes in HT22 cells","volume":"151","author":"Liu","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"97","DOI":"10.21037\/apm-20-2147","article-title":"Effects of alprostadil combined with tanshinone IIa injection on microcirculation disorder, outcomes, and cardiac function in AMI patients after PCI","volume":"10","author":"Lu","year":"2021","journal-title":"Ann. Palliat. Med."},{"key":"B31","volume-title":"Effects of tanshinone injection on myocardial reperfusion injury and different style of TCM","author":"Luan","year":"2012"},{"key":"B32","doi-asserted-by":"publisher","first-page":"524","DOI":"10.3969\/j.issn.1672-1349.2012.05.007","article-title":"Effects of tanshinone injection on myocardial ischemia-reperfusion injury and different syndromes of TCM","volume":"10","author":"Luan","year":"2012","journal-title":"Chin. J. Integr. Med. Cardio-\/Cerebrovascular Dis."},{"key":"B33","doi-asserted-by":"publisher","first-page":"2987","DOI":"10.3969\/j.issn.1004-437X.2018.16.054","article-title":"Effect of tanshinone \u2161A sulfonate injection combined with Ticagrelor on patients with acute myocardial infarction after PCI","volume":"27","author":"Luo","year":"2018","journal-title":"Henan Med. Res."},{"key":"B34","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1007\/s11655-016-2746-0","article-title":"Relationship between two blood stasis syndromes and inflammatory factors in patients with acute coronary syndrome","volume":"23","author":"Ma","year":"2017","journal-title":"Chin. J. Integr. Med."},{"key":"B35","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s10557-015-6625-2","article-title":"Rationale and design of sodium tanshinone IIA sulfonate in left ventricular remodeling secondary to acute myocardial infarction (STAMP-REMODELING) trial: A randomized controlled study","volume":"29","author":"Mao","year":"","journal-title":"Cardiovasc Drugs Ther."},{"key":"B36","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s10557-020-07077-8","article-title":"Efficacy of sodium tanshinone IIA sulfonate in patients with non-ST elevation acute coronary syndrome undergoing percutaneous coronary intervention: Results from a multicentre, controlled, randomized trial","volume":"35","author":"Mao","year":"2021","journal-title":"Cardiovasc Drugs Ther."},{"key":"B37","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.ijcard.2014.12.166","article-title":"Sodium tanshinone IIA sulfonate for reduction of periprocedural myocardial injury during percutaneous coronary intervention (STAMP trial): Rationale and design","volume":"182","author":"Mao","year":"","journal-title":"Int. J. Cardiol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1016\/s1875-5364(18)30126-2","article-title":"Sodium tanshinone IIA sulfonate attenuates cardiac dysfunction and improves survival of rats with cecal ligation and puncture-induced sepsis","volume":"16","author":"Meng","year":"2018","journal-title":"Chin. J. Nat. Med."},{"key":"B39","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"Bmj"},{"key":"B40","doi-asserted-by":"publisher","first-page":"723","DOI":"10.12102\/j.issn.1672-1349.2019.05.021","article-title":"Clinical research on tanshinone \u2161A sodium sulfonate injection in the treatment of non-ST-segment elevation acute coronary syndrome patients with blood stasis syndrome","volume":"17","author":"Pang","year":"2019","journal-title":"Chin. J. Integr. Med. Cardio-Cerebrovascular Dis."},{"key":"B41","volume-title":"The clinical study of sodium tanshinone type IIA sulfonate on non ST-segment elevation acute coronary syndrome with blood stasis patients undertaking percutaneous coronary interention","author":"Pang","year":"2016"},{"key":"B42","doi-asserted-by":"publisher","first-page":"753","DOI":"10.3389\/fphar.2019.00753","article-title":"Salvia miltiorrhiza in treating cardiovascular diseases: A review on its pharmacological and clinical applications","volume":"10","author":"Ren","year":"2019","journal-title":"Front. Pharmacol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: A revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"Bmj"},{"key":"B44","doi-asserted-by":"publisher","first-page":"7092151","DOI":"10.1155\/2019\/7092151","article-title":"Vascular inflammation and oxidative stress: Major triggers for cardiovascular disease","volume":"2019","author":"Steven","year":"2019","journal-title":"Oxid. Med. Cell Longev."},{"key":"B45","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3969\/j.issn.1008-5971.2019.09.017","article-title":"Impact of sodium tanshinone \u2161A sulfonate on postoperative acute coronary syndrome patients treated by percutaneous coronary intervention","volume":"27","author":"Tao","year":"2019","journal-title":"Pract. J. Cardiac Cereb. Pneumal Vasc. Dis."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1016\/j.jcmg.2020.08.030","article-title":"NIRS-IVUS for differentiating coronary plaque rupture, erosion, and calcified nodule in acute myocardial infarction","volume":"14","author":"Terada","year":"2021","journal-title":"JACC Cardiovasc Imaging"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.3390\/cells10061391","article-title":"Inflammation during percutaneous coronary intervention-prognostic value, mechanisms and therapeutic targets","volume":"10","author":"Tucker","year":"2021","journal-title":"Cells"},{"key":"B48","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.gene.2015.07.081","article-title":"Identification of gene variants related to the nitric oxide pathway in patients with acute coronary syndrome","volume":"574","author":"Umman","year":"2015","journal-title":"Gene"},{"key":"B49","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1177\/2047487316679521","article-title":"Combined effect of educational status and cardiovascular risk factors on the incidence of coronary heart disease and stroke in European cohorts: Implications for prevention","volume":"24","author":"Veronesi","year":"2017","journal-title":"Eur. J. Prev. Cardiol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"99","DOI":"10.16662\/j.cnki.1674-0742.2020.01.099","article-title":"Effect of sodium tanshinone IIA sulfonate combined with erythropoietin on cardiac function in patients with acute ST-segment elevation myocardial infarction after PCI","volume":"39","author":"Wen","year":"2020","journal-title":"China Foreign Med. Treat."},{"key":"B51","doi-asserted-by":"publisher","first-page":"36","DOI":"10.15887\/j.cnki.13-1389\/r.2015.29.018","article-title":"Protective effect of tanshinone \u2161A sodium sulfonate on oxidative stress injury of myocardium after interventional therapy for myocardial infarction","volume":"8","author":"Wu","year":"2015","journal-title":"J. Clin. Ration. drug use"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.3389\/fphar.2019.01542","article-title":"Efficacy and safety of sodium tanshinone IIA sulfonate injection on hypertensive nephropathy: A systematic review and meta-analysis","volume":"10","author":"Xu","year":"2019","journal-title":"Front. Pharmacol."},{"key":"B53","first-page":"129","article-title":"Analysis of the effect of tanshinone injection on acute ST-segment elevation myocardial infarction after operation","volume":"27","author":"Ye","year":"2019","journal-title":"Clin. Res."},{"key":"B54","doi-asserted-by":"publisher","first-page":"862676","DOI":"10.3389\/fsurg.2022.862676","article-title":"Effects of nifedipine tablets combined with magnesium sulfate on blood coagulation index, oxidative stress, NO and ET-1 levels in patients with pregnancy hypertension","volume":"9","author":"Yu","year":"2022","journal-title":"Front. Surg."},{"key":"B55","doi-asserted-by":"publisher","first-page":"620","DOI":"10.3969\/j.issn.1673-6966.2022.05.016","article-title":"Effects of sodium tanshinone IIA sulfonate injection combined with carvedilol in patients with acute coronary syndrome","volume":"17","author":"Yu","year":"2022","journal-title":"China J. Emerg. Resusc. Disaster Med."},{"key":"B56","doi-asserted-by":"publisher","first-page":"2424","DOI":"10.3969\/j.issn.1002-7386.2019.16.005","article-title":"The effects of tanshinone \u2161A on myocardial function and prognosis of patients with acute myocardial infarction after ischemia-reperfusion","volume":"41","author":"Zhang","year":"2019","journal-title":"Hebei Med. J."},{"key":"B57","doi-asserted-by":"publisher","first-page":"423","DOI":"10.3969\/j.issn.1674-4055.2022.04.09","article-title":"Effect of tanshinone injection on in-stent restenosis after PCI of non-ST segment elevation myocardial infarction","volume":"14","author":"Zhao","year":"2022","journal-title":"Chin. J. Evidence-Based Cardiovasc. Med."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.3969\/j.issn.1674-4659.2021.11.1515","article-title":"Analysis on the clinical effect of Tanshinone\u2161A sodium sulfonate injection in the treatment of patients with acute myocardial infarction","volume":"28","author":"Zheng","year":"2021","journal-title":"Clin. Med. Eng."},{"key":"B59","doi-asserted-by":"publisher","first-page":"384","DOI":"10.3969\/j.issn.1673-7202.2016.03.003","article-title":"Observation of Salvia miltiorrhiza intravenous agents on selective PCI perioperative myocardial injury","volume":"11","author":"Zhou","year":"2016","journal-title":"World Chin. Med."},{"key":"B60","doi-asserted-by":"publisher","first-page":"109362","DOI":"10.1016\/j.biopha.2019.109362","article-title":"Sodium tanshinone IIA sulfonate: A review of pharmacological activity and pharmacokinetics","volume":"118","author":"Zhou","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"B61","doi-asserted-by":"publisher","first-page":"6293","DOI":"10.2147\/jir.S386470","article-title":"Sodium tanshinone IIA sulfonate inhibits vascular endothelial cell pyroptosis via the AMPK signaling pathway in atherosclerosis","volume":"15","author":"Zhu","year":"2022","journal-title":"J. Inflamm. Res."},{"key":"B62","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.ejphar.2017.09.047","article-title":"Tanshinone IIA Sodium sulfonate regulates antioxidant system, inflammation, and endothelial dysfunction in atherosclerosis by downregulation of CLIC1","volume":"815","author":"Zhu","year":"2017","journal-title":"Eur. J. Pharmacol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"550","DOI":"10.3389\/fphar.2018.00550","article-title":"The therapeutic efficacy of danhong injection combined with percutaneous coronary intervention in acute coronary syndrome: A systematic review and meta-analysis","volume":"9","author":"Zou","year":"2018","journal-title":"Front. Pharmacol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2023.1144419\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,7]],"date-time":"2023-03-07T04:30:17Z","timestamp":1678163417000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2023.1144419\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,7]]},"references-count":63,"alternative-id":["10.3389\/fphar.2023.1144419"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2023.1144419","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,7]]},"article-number":"1144419"}}